Thomas E. Hogan
Known title: Chief Executive OfficerCIK: 0002013619
Associated companies
Transaction History
| CLBT | ▼ Sell | Open Market | 25,299 | $286K | 8/25/2026 | View on chart |
| CLBT | ▼ Sell | Open Market | 139,713 | $2.1M | 8/12/2026 | View on chart |
| CLBT | ▲ Buy | Grant | 339,484 | $0 | 8/11/2026 | View on chart |
| CLBT | ▼ Sell | Open Market | 103,188 | $1.6M | 7/2/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
CLBT Featured in Retail Watchlist Amid Cooling Inflation
Cellebrite was included in a Yahoo Finance article listing three US growth tech stocks that retail investors are watching due to cooling inflation. The stock is currently trading near a key support level, with an average analyst target of $15.36. This mention highlights ongoing retail interest in the company's growth potential.
CLBT Featured in Retail Watchlist Amid Cooling Inflation. Cellebrite was included in a Yahoo Finance article listing three US growth tech stocks that retail investors are watching due to cooling inflation. The stock is currently trading near a key support level, with an average analyst target of $15.36. This mention highlights ongoing retail interest in the company's growth potential.